Markets & Stocks
European Cannabis Stocks Review: InterCure Up 10% Amid More Record Results, Stenocare Secures New Funding, & More From Goodbody Health
InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15.
